Novel pharmaceutical formulation
AssigneeReckitt Benckiser N.V.
InventorsRAGHU CAVATUR, KEVIN CHEN, MATTHEW JAMES KASER, HONGCHUN QIU
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of guaifenesin, naproxen and at least one further active which is selected to be an antitussive, a decongestant or an antihistamine.
Claims54
A pharmaceutical composition comprising a pharmaceutically effective amount of guaifenesin, naproxen and at least one further active which is selected to be an antitussive, a decongestant or an antihistamine.
A pharmaceutical dosage form which comprises at least three distinct portions wherein two of the portions have immediate release characteristics and a third portion has modified release characteristics, wherein one of the immediate release portions comprises an expectorant and a second active which is an antitussive or a decongestant and the second immediate release portion comprises an analgesic having a half-life of twelve hours and wherein the modified release portion comprises guaifenesin and a second active which is an antitussive or a decongestant.
Dependencies are inferred from the claim text.